Stanniocalcin-1: A novel molecular blood and bone marrow marker for human breast cancer

Clinical Cancer Research

Volumn 9, Issue 4, 2003, Pages 1427-1435

  Wascher, Robert A ^a   Huynh, Kelly T ^a   Giuliano, Armando E ^a   Hansen, Nora M ^a   Singer, Frederick R ^a   Elashoff, David ^b   Hoon, Dave S B ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; MESSENGER RNA; STANNIOCALCIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; BONE MARROW; BONE MARROW METASTASIS; BREAST CANCER; CALCIUM HOMEOSTASIS; CANCER CELL; CANCER SCREENING; CANCER STAGING; CHROMOSOME 8P; COHORT ANALYSIS; ELECTROCHEMICAL ANALYSIS; FEMALE; GENE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

BONE MARROW CELLS; BREAST NEOPLASMS; CALCIUM; CELL LINE, TUMOR; CHEMILUMINESCENT MEASUREMENTS; COHORT STUDIES; FEMALE; GLYCOPROTEINS; HOMEOSTASIS; HUMANS; IN SITU HYBRIDIZATION; OLIGONUCLEOTIDES, ANTISENSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0037386930     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Giuliano, A. E., Kirgan, D. M., Guenther, J. M., and Morton, D. L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg., 220: 391-398, 1994.
2. Turner, R. R., Ollila, D. W., Krasne, D. L., and Giuliano, A. E. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann. Surg., 226: 271-276, 1997.
3. Hellman, S. Karnofsky Memorial Lecture: Natural history of small breast cancers. J. Clin. Oncol., 12: 2229-2234, 1994.
4. Kamby, C., and Sengelov, L. Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow up. Breast Cancer Res. Treat., 45: 181-192, 1997.
5. Chang, A. C., Janosi, J., Hulsbeek, M., de Jong, D., Jeffrey, K. J., Noble, J. R., and Reddel, R. R. A novel human cDNA highly homologous to the fish hormone stanniocalcin. Mol. Cell. Endocrinol., 112: 241-247, 1995.
6. Chang, A. C., Jeffrey, K. J., Tokutake, Y., Shimamoto, A., Neumann, A. A., Dunham, M. A., Cha, J., Sugawara, M., Furuichi, Y., and Reddel, R. R. Human stanniocalcin (STC): genomic structure, chromosomal localization, and the presence of CAG trinucleotide repeats. Genomics, 47: 393-398, 1998.
7. Wagner, G. F., Jaworski, E. M., and Haddad, M. Stanniocalcin in the seawater salmon: structure, function, and regulation. Am. J. Physiol., 274: R1177-R1185, 1998.
8. Hermsen, M. A., Baak, J. P., Meijer, G. A., Weiss, J. M., Walboomers, J. W., Snijders, P. J., and van Diest, P. J. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors. J. Pathol., 186: 356-362, 1998.
9. Anbazhagan, R., Fujii, H., and Gabrielson, E. Allelic loss of chromosomal arm 8p in breast cancer progression. Am. J. Pathol., 152: 815-819, 1998.
10. Sigbjornsdottir, B. I., Ragnarsson, G., Agnarsson, B. A., Huiping, C., Barkardottir, R. B., Egilsson, V., and Ingvarsson, S. Chromosome 8p alterations in sporadic and BRCA2 999de15 linked breast cancer. J. Med. Genet., 37: 342-347, 2000.
11. Yokota, T., Yoshimoto, M., Akiyama, F., Sakamoto, G., Kasumi, F., Nakamura, Y., and Emi, M. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1. Cancer (Phila.), 85: 447-452, 1999.
12. Varghese, R., Wong, C. K., Deol, H., Wagner, G. F., and DiMattia, G. E. Comparative analysis of mammalian stanniocalcin genes. Endocrinology, 139: 4714-4725, 1998.
13. Wagner, G. F., Vozzolo, B. L., Jaworski, E., Haddad, M., Kline, R. L., Olsen, H. S., Rosen, C. A., Davidson, M. B., and Renfro, J. L. Human stanniocalcin inhibits renal phosphate excretion in the rat. J. Bone Miner. Res., 12: 165-171, 1997.
14. Olsen, H. S., Cepeda, M. A., Zhang, Q. Q., Rosen, C. A., and Vozzolo, B. L. Human stanniocalcin: a possible hormonal regulator of mineral metabolism. Proc. Natl. Acad. Sci. USA, 93: 1792-1796, 1996.
15. Madsen, K. L., Tavernini, M. M., Yachimec, C., Mendrick, D. L., Alfonso, P. J., Buergin, M., Olsen, H. S., Antonaccio, M. J., Thomson, A. B., and Fedorak, R. N. Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine. Am. J. Physiol., 274: 96-102, 1998.
16. DiMattia, G. E., Varghese, R., and Wagner, G. F. Molecular cloning and characterization of stanniocalcin-related protein. Mol. Cell. Endocrinol., 146: 137-140, 1998.
17. Wagner, G. F., Hampong, M., Park, C. M., and Copp, D. H. Purification, characterization, and bioassay of teleocalcin, a glycoprotein from salmon corpuscles of Stannius. Gen. Comp. Endocrinol., 63: 481-491, 1986.
18. Slade, M. J., Smith, B. M., Sinnett, H. D., Cross, N. C., and Coombes, R. C. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J. Clin. Oncol., 17: 870-879, 1999.
19. Bostick, P. J., Chatterjee, S., Chi, D. D., Huynh, K. T., Giuliano, A. E., Cote, R., and Hoon, D. S. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J. Clin. Oncol., 16: 2632-2640, 1998.
20. Brugger, W., Buhring, H. J., Grunebach, F., Vogel, W., Kaul, S., Muller, R., Brummendorf, T. H., Ziegler, B. L., Rappold, I., Brossart, P., Scheding, S., and Kanz, L. Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. J. Clin. Oncol., 17: 1535-1544, 1999.
21. Lambrechts, A. C., Bosma, A. J., Klaver, S. G., Top, B., Perebolte, L., van't Veer, L. J., and Rodenhuis, S. Comparison of immunocyto-chemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cells. Breast Cancer Res. Treat., 56: 219-231, 1999.
22. Merrie, A. E., Yun, K., Gunn, J., Phillips, L. V., and McCall, J. L. Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer. Br. J. Cancer, 80: 2019-2024, 1999.
23. Hoon, D. S., Wang, Y., Dale, P. S., Conrad, A. J., Schmid, P., Garrison, D., Kuo, C., Foshag, L. J., Nizze, A. J., and Morton, D. L. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J. Clin. Oncol., 13: 2109-2116, 1995.
24. Miyashiro, I., Kuo, C., Huynh, K., Iida, A., Morton, D., Bilchik, A., Giuliano, A., and Hoon, D. S. Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes. Clin. Chem., 47: 505-512, 2001.
25. O'Connell, C. D., Juhasz, A., Kuo, C., Reeder, D. J., and Hoon, D. S. Detection of tyrosinase mRNA in melanoma by reverse transcription-PCR and electrochemiluminescence. Clin. Chem., 44: 1161-1169, 1998.
26. Bilchik, A., Miyashiro, M., Kelley, M., Kuo, C., Fujiwara, Y., Nakamori, S., Monden, M., and Hoon, D. S. Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay. Cancer (Phila.), 88: 1037-1044, 2000.
27. Hoon, D. S., Sarantou, T., Doi, F., Chi, D. D., Kuo, C., Conrad, A. J., Schmid, P., Turner, R., and Guiliano, A. Detection of metastatic breast cancer by β-hCG polymerase chain reaction. Int. J. Cancer, 69: 369-374, 1996.
28. Solomayer, E. F., Diel, I. J., Salanti, G., Hahn, M., Gollan, C., Schutz, F., and Bastert, G. Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients. Clin. Cancer Res., 7: 4102-4108, 2001.
29. Ooka, M., Tamaki, Y., Sakita, I., Fujiwara, Y., Yamamoto, H., Miyake, Y., Sekimoto, M., Ohue, M., Sugita, Y., Miyoshi, Y., Ikeda, N., Noguchi, S., and Monden, M. Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer. Breast Cancer Res. Treat., 67: 169-175, 2001.
30. Janni, W., Hepp, F., Rjosk, D., Kentenich, C., Strobl, B., Schindlbeck, C., Hantschmann, P., Sommer, H., Pantel, K., and Braun, S. The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence. Cancer (Phila.), 92: 46-53, 2001.
31. Braun, S., Cevatli, B. S., Assemi, C., Janni, W., Kentenich, C. R., Schindlbeck, C., Rjosk, D., and Hepp, F. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. J. Clin. Oncol., 19: 1468-1475, 2001.
32. Gerber, B., Krause, A., Muller, H., Richter, D., Reimer, T., Makovitzky, J., Herrnring, C., Jeschke, U., Kundt, G., and Friese, K. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. J. Clin. Oncol., 19: 960-971, 2001.
33. Braun, S., Pantel, K., Muller, P., Janni, W., Hepp, F., Kentenich, C. R., Gastroph, S., Wischnik, A., Dimpfl, T., Kindermann, G., Riethmuller, G., and Schlimok, G. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N. Engl. J. Med., 342: 525-533, 2000.
34. Pantel, K., Cote, R. J., and Fodstad, O. Detection and clinical importance of micrometastatic disease. J. Natl. Cancer. Inst. (Bethesda), 91: 1113-1124, 1999.
35. Zach, O., Kasparu, H., Krieger, O., Hehenwarter, W., Girschikofsky, M., and Lutz, D. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J. Clin. Oncol., 17: 2015-2019, 1999.
36. Smith, B. M., Slade, M. J., English, J., Graham, H., Luchtenborg, M., Sinnett, H. D., Cross, N. C., and Coombes, R. C. Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. J. Clin. Oncol., 18: 1432-1439, 2000.
37. Taback, B., Chan, A. D., Kuo, C. T., Bostick, P. J., Wang, H. J., Giuliano, A. E., and Hoon, D. S. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res., 61: 8845-8850, 2001.
38. Mansi, J. L., Gogas, H., Bliss, J. M., Gazet, J. C., Berger, U., and Coombes, R. C. Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet, 354: 197-202, 1999.
39. Naume, B., Borgen, E., Kvalheim, G., Karesen, R., Qvist, H., Sauer, T., Kumar, T., and Nesland, J. M. Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. Clin. Cancer Res., 7: 4122-4129, 2001.
40. th ed., pp. 319-343. New York: McGraw-Hill Companies, 2002.
41. Pantel, K., and Braun, S. Molecular determinants of occult metastatic tumor cells in bone marrow. Clin. Breast Cancer, 2: 222-228, 2001.
42. Lal, A., Peters, H., St Croix, B., Haroon, Z. A., Dewhirst, M. W., Strausberg, R. L., Kaanders, J. H., van der Kogel, A. J., and Riggins, G. J. Transcriptional response to hypoxia in human tumors. J. Natl. Cancer Inst. (Bethesda), 93: 1337-1343, 2001.
43. Fitzgibbons, P. L., Page, D. L., Weaver, D., Thor, A. D., Allred, D. C., Clark, G. M., Ruby, S. G., O'Malley, F., Simpson, J. F., Connolly, J. L., Hayes, D. F., Edge, S. B., Lichter, A., and Schnitt, S. J. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch. Pathol. Lab. Med., 124: 966-978, 2000.